1nxu
From Proteopedia
|
CRYSTAL STRUCTURE OF E. COLI HYPOTHETICAL OXIDOREDUCTASE YIAK NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER82.
Overview
Escherichia coli YiaK catalyzes the reduction of 2,3-diketo-L-gulonate in, the presence of NADH. It belongs to a large family of oxidoreductases that, is conserved in archaea, bacteria, and eukaryotes but shows no sequence, homology to other proteins. We report here the crystal structures at up to, 2.0-A resolution of YiaK alone and in complex with NAD-tartrate. YiaK has, a new polypeptide backbone fold and a novel mode of recognizing the NAD, cofactor. In addition, NAD is bound in an unusual conformation, at the, interface of a dimer of the enzyme. The crystallographic analysis, unexpectedly revealed the binding of tartrate in the active site. Enzyme, kinetics studies confirm that tartrate and the related D-malate are, inhibitors of YiaK. In contrast to most other enzymes where substrate, binding produces a more closed conformation, the binding of NAD-tartrate, to YiaK produces a more open active site. The free enzyme conformation is, incompatible with NAD binding. His(44) is likely the catalytic residue of, the enzyme.
About this Structure
1NXU is a Single protein structure of sequence from Escherichia coli with SO4 as ligand. Full crystallographic information is available from OCA.
Reference
A novel NAD-binding protein revealed by the crystal structure of 2,3-diketo-L-gulonate reductase (YiaK)., Forouhar F, Lee I, Benach J, Kulkarni K, Xiao R, Acton TB, Montelione GT, Tong L, J Biol Chem. 2004 Mar 26;279(13):13148-55. Epub 2004 Jan 12. PMID:14718529
Page seeded by OCA on Tue Nov 20 22:38:48 2007
Categories: Escherichia coli | Single protein | Acton, T.B. | Benach, J. | Forouhar, F. | Kulkarni, K. | Lee, I. | Montelione, G.T. | NESG, Northeast.Structural.Genomics.Consortium. | Rost, B. | Shastry, R. | Tong, L. | Xiao, R. | SO4 | Hypothetical protein | Nesg | Northeast structural genomics consortium | Oxidoreductase | Protein structure initiative | Psi | Structural genomics